Latest News

Featured News

Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody^® iSCIB1+

Jul 22, 2025

Interim Results and Business Update

January 29, 2026

Scancell announces FDA clearance of IND application for global Phase 3 trial of iSCIB1+ in advanced melanoma

January 26, 2026

Notice of Interim Results and Investor Presentation

January 22, 2026

Scancell updated Phase 2 data shows continued improvement in progression free survival with iSCIB1+

December 9, 2025

Scancell to present positive Phase 2 data on Immunobody^® iSCIB1+ in late-stage melanoma at SITC 2025

November 7, 2025

Results of 2025 Annual General Meeting

October 30, 2025

4
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
5

No results found.

Regulatory News Archive

JOIN OUR MAILING LIST

Sign up for news updates to stay up to date with Scancell.